{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T11:20:54Z","timestamp":1789212054825,"version":"build-2803163510"},"reference-count":35,"publisher":"The Endocrine Society","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1997,8,1]]},"DOI":"10.1210\/endo.138.8.5340","type":"journal-article","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T11:09:00Z","timestamp":1389179340000},"page":"3269-3275","source":"Crossref","is-referenced-by-count":8,"title":["Tamoxifen Attenuates Glucocorticoid Actions on Bone Formation in Vitro*"],"prefix":"10.1210","volume":"138","author":[{"given":"B.","family":"Sukhu","sequence":"first","affiliation":[{"name":"The Samuel Lunenfeld Research Institute of Mount Sinai Hospital (B.S., B.R., H.K., H.C.T.), University of Toronto, Toronto, Ontario, Canada M5G 1X5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Rotenberg","sequence":"additional","affiliation":[{"name":"The Samuel Lunenfeld Research Institute of Mount Sinai Hospital (B.S., B.R., H.K., H.C.T.), University of Toronto, Toronto, Ontario, Canada M5G 1X5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Binkert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Kohno","sequence":"additional","affiliation":[{"name":"The Samuel Lunenfeld Research Institute of Mount Sinai Hospital (B.S., B.R., H.K., H.C.T.), University of Toronto, Toronto, Ontario, Canada M5G 1X5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Zohar","sequence":"additional","affiliation":[{"name":"Medical Research Council Group in Periodontal Physiology (C.A.G.M., R.Z., H.C.T.), University of Toronto, Toronto, Ontario, Canada M5G 1X5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. A. G.","family":"McCulloch","sequence":"additional","affiliation":[{"name":"The Faculty of Dentistry (C.A.G.M., H.C.T.), University of Toronto, Toronto, Ontario, Canada M5G 1X5"},{"name":"Medical Research Council Group in Periodontal Physiology (C.A.G.M., R.Z., H.C.T.), University of Toronto, Toronto, Ontario, Canada M5G 1X5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. C.","family":"Tenenbaum","sequence":"additional","affiliation":[{"name":"The Faculty of Dentistry (C.A.G.M., H.C.T.), University of Toronto, Toronto, Ontario, Canada M5G 1X5"},{"name":"Medical Research Council Group in Periodontal Physiology (C.A.G.M., R.Z., H.C.T.), University of Toronto, Toronto, Ontario, Canada M5G 1X5"},{"name":"The Samuel Lunenfeld Research Institute of Mount Sinai Hospital (B.S., B.R., H.K., H.C.T.), University of Toronto, Toronto, Ontario, Canada M5G 1X5"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2019041120230192600_R1","first-page":"307","article-title":"Tamoxifen: oestrogen or anti-oestrogen in bone?","volume":"88","author":"Wright","year":"1995","journal-title":"Q J Med"},{"key":"2019041120230192600_R2","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0169-6009(91)90002-H","article-title":"A comparative study of the actions of tamoxifen, estrogen and progesterone in the ovariectomized rat.","volume":"15","author":"Kalu","year":"1991","journal-title":"Bone Miner"},{"key":"2019041120230192600_R3","first-page":"176","article-title":"The role of tamoxifen in the prevention and treatment of benign and malignent breast lesions: a chemopreventative.","volume":"78","author":"Leis","year":"1993","journal-title":"Int Surg"},{"key":"2019041120230192600_R4","first-page":"33","article-title":"Tamoxifen prophylaxis in breast cancer.","volume":"6","author":"Love","year":"1992","journal-title":"Oncology"},{"key":"2019041120230192600_R5","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0960-0760(95)00084-D","article-title":"Anti-estrogens: mechanism and actions in target cells.","volume":"53","author":"Katzenellenbogen","year":"1995","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041120230192600_R6","first-page":"3073","article-title":"Effect of aromatase inhibitors on growth of mammary tumors in a nude mouse model.","volume":"55","author":"Yue","year":"1995","journal-title":"Cancer Res"},{"key":"2019041120230192600_R7","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/jnci\/88.5.279","article-title":"Role of c-myc in tamoxifen-induced apoptosis in estrogen-independent breast cancer cells.","volume":"88","author":"Kang","year":"1996","journal-title":"J Natl Cancer Inst"},{"key":"2019041120230192600_R8","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/BF01833337","article-title":"Tamoxifen reduces serum insulin-like growth factor I (IGF-I).","volume":"22","author":"Pollak","year":"1992","journal-title":"Breast Cancer Res Treat"},{"key":"2019041120230192600_R9","first-page":"1581","article-title":"Combined chemoendocrine treatment with tegafur and tamoxifen for advanced renal cell carcinoma.","volume":"15","author":"Wada","year":"1995","journal-title":"Anticancer Res"},{"key":"2019041120230192600_R10","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/BF01627077","article-title":"Apparent beneficial effects of tamoxifen on bone mineral content in patients with breast cancer: preliminary study.","volume":"2","author":"Ryan","year":"1991","journal-title":"Osteoporosis Int"},{"key":"2019041120230192600_R11","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0169-6009(89)90081-0","article-title":"Antiestrogen and antiandrogen administration reduce bone mass in the rat.","volume":"7","author":"Feldmann","year":"1989","journal-title":"Bone Miner"},{"key":"2019041120230192600_R12","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0169-6009(08)80220-6","article-title":"Tamoxifen reduces bone turnover and prevents lumbar spine and proximal femoral bone loss in early postmenopausal women.","volume":"22","author":"Ward","year":"1993","journal-title":"Bone Miner"},{"key":"2019041120230192600_R13","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0169-6009(91)90023-S","article-title":"Effects of estrogen and tamoxifen on serum osteocalcin levels in ovariectomized rats.","volume":"14","author":"Williams","year":"1991","journal-title":"Bone Miner"},{"key":"2019041120230192600_R14","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1210\/mend-5-11-1597","article-title":"Functional estrogen receptors in osteoblastic cells demonstrated by transfection with a reporter gene containing an estrogen response element.","volume":"5","author":"Ernst","year":"1991","journal-title":"Mol Endocrinol"},{"key":"2019041120230192600_R15","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S0959-8049(05)80125-X","article-title":"Tamoxifen protects against steroid-induced bone loss.","volume":"28","author":"Fentiman","year":"1992","journal-title":"Eur J Cancer"},{"key":"2019041120230192600_R16","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1002\/jbmr.5650070909","article-title":"Estrogen and progesterone replacement therapy reduces glucocorticoid-induced bone loss.","volume":"7","author":"Lukert","year":"1992","journal-title":"J Bone Miner Res"},{"key":"2019041120230192600_R17","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/8756-3282(95)00138-4","article-title":"Progesterone antagonist RU 486 has bone-sparing effects in ovariectomized rats.","volume":"17","author":"Barengolts","year":"1995","journal-title":"Bone"},{"key":"2019041120230192600_R18","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/BF02411212","article-title":"Differentiation of osteoblasts and formation of mineralized bone in vitro.","volume":"34","author":"Tenenbaum","year":"1982","journal-title":"Calcif Tissue Int"},{"key":"2019041120230192600_R19","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/BF00225804","article-title":"Bone formation in vitro by stromal cells obtained from bone marrow of young adult rats.","volume":"254","author":"Maniatopoulos","year":"1988","journal-title":"Cell Tissue Res"},{"key":"2019041120230192600_R20","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1210\/endo-116-1-170","article-title":"Glucocorticoid regulation of alkaline phosphatase in the osteoblastic osteosarcoma cell line ROS 17\/2.8.","volume":"116","author":"Majeska","year":"1985","journal-title":"Endocrinology"},{"key":"2019041120230192600_R21","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/ar.1092420209","article-title":"Probing glucocorticoid-dependent osteogenesis in rat and chick cells by specific blockage of osteoblastic differentiation with progesterone and RU38486.","volume":"242","author":"Tenenbaum","year":"1995","journal-title":"Anat Rec"},{"key":"2019041120230192600_R22","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1002\/jbmr.5650081111","article-title":"Cell signaling and estrogens in female rat osteoblasts: a possible involvement of unconventional nonnuclear receptors.","volume":"8","author":"Lieberherr","year":"1993","journal-title":"J Bone Miner Res"},{"key":"2019041120230192600_R23","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S8756-3282(95)80265-7","article-title":"Effects of bisphosphonates ADP and HEBP on bone metabolism in vitro.","volume":"16","author":"Goziotis","year":"1995","journal-title":"Bone"},{"key":"2019041120230192600_R24","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1074\/jbc.271.22.12755","article-title":"Fetuin\/\u03b12-HS glycoprotein is a transforming growth factor \u03b2 type II mimic and cytokine antagonist.","volume":"271","author":"Demetriou","year":"1996","journal-title":"J Biol Chem"},{"key":"2019041120230192600_R25","first-page":"156","article-title":"Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.","volume":"162","author":"Chomcynski","year":"1987","journal-title":"Anal Biochem"},{"key":"2019041120230192600_R26","author":"Sambrook","year":"1989","edition":"ed 2"},{"key":"2019041120230192600_R27","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/jcp.1041650115","article-title":"Concanavalin-A induced apoptosis in fibroblast: the role of cell surface carbohydrates in lactin-mediated cytotoxicity.","volume":"165","author":"Kulkarni","year":"1995","journal-title":"J Cell Physiol"},{"key":"2019041120230192600_R28","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0006-291X(88)81232-4","article-title":"Interaction of antiglucocorticoid RU 486 with rat kidney glucocorticoid receptor.","volume":"153","author":"Kalimi","year":"1988","journal-title":"Biochem Biophys Res Commun"},{"key":"2019041120230192600_R29","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/8756-3282(94)90273-9","article-title":"In the ovariectomized rat, tamoxifen conserves bone similarly in parathyroid-intact and parathyroidectomized animals.","volume":"15","author":"Goulding","year":"1994","journal-title":"Bone"},{"key":"2019041120230192600_R30","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1006\/bbrc.1995.1660","article-title":"Tamoxifen directly stimulates the mineralization of human osteoblast-like osteosarcoma cells through a pathway independent of estrogen response element.","volume":"210","author":"Takeuchi","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"key":"2019041120230192600_R31","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1016\/0959-8049(93)90218-5","article-title":"Type I IGF-receptor and acquired tamoxifen resistance in oestrogen-responsive human breast cancer cells","volume":"29A","author":"Wiseman","year":"1993","journal-title":"Eur J Cancer"},{"key":"2019041120230192600_R32","first-page":"3115","article-title":"Uterotrophic actions of estradiol and tamoxifen are associated with inhibition of uterine insulin-like growth factor binding protein 3 gene expression.","volume":"54","author":"Huynh","year":"1994","journal-title":"Cancer Res"},{"key":"2019041120230192600_R33","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/0167-4889(89)90029-3","article-title":"Cytostatic effect of anti-estrogens in lymphoid cells: relationship to high affinity anti-estrogen-binding sites and cholesterol.","volume":"1014","author":"Tang","year":"1989","journal-title":"Biochim Biophys Acta"},{"key":"2019041120230192600_R34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00230867","article-title":"Molecular mechanisms of RU 486 action: a review.","volume":"109","author":"Mao","year":"1992","journal-title":"Mol Cell Biochem"},{"key":"2019041120230192600_R35","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/328624a0","article-title":"Antiglucocorticoid effects suggest why steroid hormones are required for receptors to bind DNA in vivo but not in vitro.","volume":"328","author":"Groyer","year":"1987","journal-title":"Nature"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/138\/8\/3269\/10355588\/endo3269.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T03:03:15Z","timestamp":1555038195000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/138\/8\/3269\/2987794"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,8,1]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[1997,8,1]]}},"URL":"https:\/\/doi.org\/10.1210\/endo.138.8.5340","relation":{},"ISSN":["0013-7227","1945-7170"],"issn-type":[{"value":"0013-7227","type":"print"},{"value":"1945-7170","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,8,1]]}}}